Regen BioPharma Inc (RGBP)

[Mysterium]

$RGBP Thanks for that post, CV. I especially like the last paragraph:

These are 3 separate pipeline developments. Furthermore, keep in mind that C. Ichim's contract gave her 18 months to acquire all her incentive shares and she signed a contract that gave her bonus shares for establishment of 3 INDs and 3 contracts for clinical trials as I recall. Those bonus shares expire June 2016. So, in their minds, there was a real possibility of having 3 pipeline products in clinical trials by June 2016.

Also need be mentioned is Harry Lander and his role(s), along with the scientific advisory board members and all of their connections and specializations. The company is only getting better; and there is now adequate DD for all to take notice of. Great post!